Regulatory News
Friday, July 22, 2016
BRIEF-Valeant says no safety concerns, additional clinical trials for approval of Latanoprostene Bunod
July 22 (Reuters) - Valeant Pharmaceuticals International
Inc
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment